United States · Platforms & data · MarketBeat
Amrize (NYSE:AMRZ) Stock Gets Price Target Increase from UBS Group

Detailed summary
UBS Group raised their price objective on Amrize from $42.00 to $46.00 and gave the company a "neutral" rating in a report on Monday.
MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.marketbeat.com)




